use
standard
cellular
fusion
techniqu
indirect
enzymelink
immunosorb
assay
elisa
hybridoma
cell
line
strain
secret
antihb
monoclon
antibodi
mab
defin
mab
obtain
cell
grew
secret
mab
stabli
antibodi
titer
cultur
supernat
ascit
respect
appli
antihb
mab
horseradish
peroxidas
hrp
label
goat
antihb
antibodi
develop
sandwich
elisa
defin
elisa
detect
wildtyp
immun
escap
mutant
hbsag
iem
hbsag
assay
perform
detect
speci
genom
recombin
express
hbsag
includ
two
wildtyp
speci
iem
hbsag
speci
vari
determin
group
patient
infect
hepat
b
viru
hbv
patient
previous
lower
elisa
detect
signal
absorb
patientsabsorb
normal
peopl
pn
result
demonstr
sensit
assay
wildtyp
hbsag
less
iem
hbsag
speci
posit
mab
posit
iem
hbsag
speci
two
low
absorb
valu
nm
one
intermedi
valu
nine
high
valu
mean
wildtyp
valu
respect
two
speci
low
valu
three
neg
speci
mutat
base
first
loop
hbv
determin
use
elisa
two
commerci
elisa
kit
b
patient
test
elisa
significantli
higher
detect
rate
either
commerci
elisa
vs
respect
p
p
respect
ongo
epidem
hepat
b
viru
hbv
one
seriou
public
health
issu
world
viru
polymeras
enzym
lack
proofread
activ
like
much
higher
mutat
frequenc
polymeras
dna
virus
mutat
develop
specif
gene
region
determin
shift
occur
express
hepat
b
surfac
antigen
hbsag
result
hbv
immun
escap
mutant
strain
hbv
iem
mani
research
demonstr
immun
escap
mutant
hbv
iem
hbv
similar
wildtyp
hbv
pathogenesi
infect
mutant
viru
neutral
protect
antibodi
alreadi
circul
bodi
commerci
kit
detect
possibl
clinic
misdiagnos
given
infecti
hbv
patient
blood
donor
screen
serum
epidemiolog
investig
becom
unreli
result
problem
attract
much
attent
group
begun
investig
phenomenon
goe
back
last
centuri
new
monoclon
antibodi
mab
produc
cell
line
antihb
mab
demonstr
strong
capac
combin
mass
iem
hbsag
studi
primarili
evalu
bind
abil
mab
hbv
mutant
determin
balbc
mice
provid
experiment
anim
center
hubei
center
diseas
control
prevent
wuhan
china
hbv
dane
particl
genom
recombin
express
hbsag
al
oh
gel
obtain
wuhan
institut
biolog
product
china
cell
obtain
china
center
type
cultur
collect
wuhan
china
cultur
medium
purchas
gibco
corpor
usa
goat
antimous
igg
horseradish
peroxidas
hrp
label
goat
antimous
igg
purchas
american
pierc
corpor
usa
hrplabel
goat
antihb
commerci
hbsag
enzymelink
immunosorb
assay
elisa
kit
procur
market
antihb
mab
antihb
mt
mab
purchas
wuhan
institut
biolog
product
china
hbsag
prepar
group
highli
concentr
hbsag
qualiti
control
blood
serum
obtain
market
express
product
wildtyp
hbv
protein
recombin
iem
hbv
protein
collect
divis
clinic
immunolog
laboratori
tongji
hospit
china
enrol
includ
patient
male
averag
age
ae
year
previous
examin
use
hbsag
kit
collect
clinic
laboratori
hospit
septemb
novemb
detect
valu
absorb
patientsabsorb
normal
peopl
pn
rang
common
commerci
elisa
kit
use
screen
control
group
includ
colleg
freshmen
took
physic
examin
school
year
student
receiv
hepat
b
viru
vaccin
longer
one
year
previous
posit
antihepat
b
surfac
antibodi
antihb
neg
hepat
b
surfac
antigen
hbsag
hepat
b
e
antigen
hbeag
antihepat
b
e
antigen
antihb
antihepat
b
core
antigen
antihbc
hbv
dna
physic
biochem
examin
indic
normal
antihb
mab
prepar
previous
report
qian
et
al
briefli
balbc
mice
immun
routin
hbv
dane
particl
fraction
extract
sera
infect
patient
three
day
follow
last
immun
mice
kill
spleen
cell
isol
cell
mix
cell
ratio
antihb
hybridoma
line
prepar
cell
fusion
limit
dilut
screen
ascit
induc
pristan
total
protein
content
ascit
determin
nm
use
ultravioletvis
spectrophotomet
bovin
serum
albumin
bsa
use
standard
protein
quantif
antihb
mab
purifi
use
capryl
acidammonium
sulfat
fraction
elisa
dualantibodi
sandwich
elisa
develop
group
use
antihb
mab
hrplabel
goatantihb
igg
accord
follow
procedur
antihb
mab
dilut
carbon
buffer
ph
distribut
microwel
plate
incub
overnight
coat
microwel
plate
wash
time
phosphat
buffer
salin
pb
tween
microwel
plate
block
gl
bsa
incub
h
liquid
discard
undetect
contrast
sampl
ad
allow
react
min
wash
goat
antihbshrp
igg
ad
well
incub
min
wash
tmbh
ad
well
incub
min
reaction
termin
addit
h
moll
well
sampl
measur
use
micropl
reader
valu
confirm
posit
criterion
neutral
assay
develop
laboratori
antihb
mab
ad
hbsag
rwhbsag
incub
room
temperatur
min
mixtur
transfer
microwel
plate
coat
mt
mab
mab
incub
min
wash
three
time
pbstween
hrplabel
goat
antihb
igg
ad
well
incub
wash
tmbh
ad
incub
valu
measur
elisa
inhibit
rate
calcul
compar
valu
nonneutr
well
examin
commonlyus
commerci
hbsag
elisa
kit
perform
accord
manufactur
instruct
statist
analys
perform
use
softwar
p
consid
statist
signific
hybridoma
line
high
secret
capac
antihb
mab
select
hybridoma
prepar
routin
cell
fusion
ascit
antihb
mab
induc
pristan
antihb
mab
igg
purifi
use
capryl
acidammonium
sulfat
fraction
cell
cultur
supernat
ascit
purifi
antibodi
antihb
mab
igg
examin
use
ultravioletvis
spectrophotomet
sandwich
elisa
titer
antihb
supernat
ascit
purifi
product
detect
elisa
respect
protein
concentr
ascit
purifi
antibodi
gl
respect
valu
serial
dilut
qualitycontrol
hbsagposit
serum
detect
elisa
compar
recombin
mutant
hbsag
express
product
condens
cultur
supernat
fig
color
intens
slope
linear
dilut
curv
similar
respect
control
serum
still
posit
pn
valu
concentr
hbsag
use
examin
genom
recombin
express
variant
sampl
mutat
determin
result
compar
wildtyp
non
determin
mutant
tabl
react
iem
hbsag
color
intens
stronger
recombin
wildtyp
hbsag
rwhbsag
twelv
recombin
iem
hbv
protein
determin
mutat
detect
differ
commerci
elisa
kit
trace
antibodi
replac
hrplabel
goat
antihb
averag
color
rate
protein
calcul
use
homochron
detect
signal
two
recombin
wild
genom
express
product
baselin
result
compar
tabl
differ
antigen
bind
site
antihb
mab
antihb
mab
analyz
doubl
antibodi
sandwich
elisa
microwel
plate
coat
purifi
antihb
mt
antihb
mab
reaction
rwhbsag
hbsag
mt
mab
block
antihb
mab
tabl
former
much
lower
effect
block
concentr
neutral
rate
reaction
rwhbsag
could
block
high
concentr
antihb
mab
reaction
hbsag
reaction
condit
antihb
mab
antihb
mt
mab
test
abil
block
hbsag
neutral
plate
fulli
coat
wildtyp
hbsag
neutral
concentr
mgl
averag
rate
neutral
antihb
mab
antihb
mt
mab
respect
two
commerci
elisa
kit
b
c
compar
abil
detect
hbsag
group
specif
clinic
sera
sensit
two
commerci
elisa
kit
b
c
ngml
respect
posit
detect
rate
elisa
case
two
commerci
elisa
kit
b
c
respect
p
respect
also
signific
differ
posit
detect
rate
two
commerci
elisa
kit
b
c
p
result
indic
antihb
mab
mab
mt
mab
bound
differ
antigen
determin
hbsag
distanc
bind
site
includ
framework
space
distanc
antihb
mab
antihb
correspond
antigen
determin
rwhbsag
far
still
correl
two
antigen
determin
antihb
mab
could
effect
block
bind
antihb
mtmab
either
wildtyp
hbsag
howev
differ
block
effici
suggest
distanc
correspond
antigen
determin
antihb
mab
antihb
mtmab
shorter
antihb
mab
antihb
presum
differ
abil
antihb
mab
bind
two
antigen
result
spatial
chang
protein
framework
mutant
wildtyp
hbv
import
clinic
diagnosi
epidemiolog
investig
hbv
iem
infect
detect
gene
antigen
antibodi
method
posit
rate
posit
coverag
detect
variou
clinic
signific
also
differ
sinc
earli
mani
research
studi
difficulti
detect
iem
hbsag
attempt
increas
clinic
detect
rate
hbsag
use
kit
coat
polyclon
antibodi
highaffin
antibodi
non
determin
hbsag
group
mab
determin
differ
iem
hbsag
prevent
common
health
problem
caus
falseneg
diagnos
hbv
infect
sinc
mani
domest
elisa
kit
abl
detect
iem
hbsag
degre
howev
detect
product
similar
detect
rate
abbott
chemiluminesc
avail
attempt
prepar
mab
reliabl
clinic
diagnosi
hbv
infect
obtain
one
hybridoma
cell
line
secret
antihbsag
antibodi
name
systemat
assess
demonstr
cell
line
could
secret
antibodi
high
effici
secret
antibodi
equal
better
specif
affin
correspond
antibodi
current
avail
commerci
kit
sensit
elisa
less
ngml
base
abil
detect
wildtyp
hbsag
analysi
suggest
bind
abil
mab
iem
rhbsag
follow
characterist
mab
could
detect
iem
rhbsag
mab
previous
report
reaction
degre
show
evid
charact
either
high
low
addit
capabl
detect
iem
rhbsag
better
commerci
kit
abil
bind
iem
hbsag
mutat
amino
acid
sequenc
site
locat
determin
antigen
loop
ii
plasmid
product
level
equal
wildtyp
hbsag
markedli
weaker
bind
site
replac
mutant
mutat
locat
either
begin
nearbi
determin
loop
includ
amino
acid
sequenc
site
bind
abil
site
mutant
determin
loop
equal
wildtyp
hbsag
exist
differ
abil
mab
bind
site
mutant
differ
amino
acid
replac
specif
rule
regard
abil
mab
bind
multisit
mutant
howev
hbsag
mutat
middl
tail
determin
loop
ii
could
degre
improv
poor
reaction
caus
mutat
begin
loop
mab
abl
bind
hbsab
mutat
outsid
determin
well
could
wildtyp
relationship
structur
iem
hbsag
degre
antigen
shift
attract
much
attent
et
al
found
main
reason
declin
affin
iem
mutant
primari
antibodi
wildtyp
hbsag
differ
water
affin
origin
amino
acid
substitut
hou
et
al
demonstr
two
patient
infect
iem
hbv
mutat
amino
acid
iem
hbsag
posit
detect
even
use
antihb
polyclon
antibodi
result
verifi
studi
hand
site
key
amino
acid
site
determin
hbv
serotyp
suggest
special
associ
antigen
shift
special
site
eg
antigen
bind
site
antihb
mab
group
determin
hbv
strong
antigen
shift
highli
associ
mutat
site
block
test
demonstr
antigen
bind
site
antihb
antihb
mt
mab
independ
antihb
mab
could
block
reaction
antihb
antihb
mt
rwhbsag
degre
block
limit
abil
block
antihb
lower
latter
suggest
correspond
antigen
determin
antihb
mab
independ
antihb
antihb
mt
mab
primari
structur
addit
suggest
significantli
larger
spatial
distanc
correspond
antigen
determin
antihb
mab
antihb
mab
antihb
mab
antihb
mt
mab
specif
antihb
mab
determin
nearbi
site
hbsag
definit
conclud
exist
distanc
amino
acid
sequenc
correspond
antigen
determin
antihb
mab
hbsag
determin
studi
serum
sampl
examin
use
elisa
two
commerci
elisa
kit
b
c
result
demonstr
elisa
commerci
elisa
kit
b
c
similar
sensit
ngml
respect
posit
rate
case
respect
neg
serum
correctli
identifi
elisa
two
commerci
elisa
kit
togeth
data
indic
elisa
stronger
capabl
detect
hbsag
commerci
elisa
kit
mab
strong
sensit
wildtyp
hbsag
ngml
commerci
elisa
kit
block
effici
hbsag
greater
wildtyp
hbsag
coat
antihb
mt
mab
tabl
detect
iem
hbsag
elisa
signal
intens
stronger
test
commerci
elisa
kit
andor
antihb
mab
tabl
presum
sera
detect
hbsag
posit
use
elisa
contain
iem
hbv
recent
studi
ijaz
louisirirotchanakul
et
al
also
provid
clinic
evid
